-
AN EFFECTIVE METHODOLOGICAL FRAMEWORK FOR EXECUTING MULTINATIONAL, PATIENT-CENTRED CROSS-SECTIONAL SURVEYS IN RARE DISEASES: FACILITATING EVIDENCE GENERATION WITH GENERALISABILITY ACROSS CONDITIONS TO SUPPORT COMMERCIAL VIABILITY
Mar 18, 2026, 21:38 PM -
ARTIFICIAL INTELLIGENCE (AI) IN ONCOLOGY HEALTH TECHNOLOGY ASSESSMENT (HTA): CURRENT APPLICATIONS, LIMITATIONS, AND IMPLICATIONS FOR LIVING-HTA
Mar 18, 2026, 21:38 PM -
THE COST OF PERFORMING FEES: ESTIMATING ANNUALIZED COSTS OF MOBILE FEES PROVIDERS FOR LTACH AND SNFS
Mar 18, 2026, 21:38 PM -
DEVELOPING DIRECT EQUITY WEIGHTS FOR COST-EFFECTIVENESS ANALYSIS: RESULTS FROM A US-BASED DISCRETE CHOICE EXPERIMENT
Mar 18, 2026, 21:38 PM -
A U.S.-SPECIFIC BUDGET IMPACT MODEL (BIM) OF SEMAGLUTIDE 2.4 MG IN THE TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) USING MOST FAVORED NATION (MFN) PRICING
Mar 18, 2026, 21:38 PM -
LONG-TERM TRENDS IN PRESCRIPTION MEDICATION CLASS USE AMONG ADULTS IN THE UNITED STATES, 2010-2023
Mar 18, 2026, 21:38 PM -
UNLOCKING THE SOCIOECONOMIC BENEFITS OF ADULT RESPIRATORY VACCINATION IN MEXICO: THE CASE FOR BROADER PREVENTION STRATEGIES
Mar 18, 2026, 21:38 PM -
HEALTHCARE COSTS AND CLINICAL OUTCOMES IN PATIENTS WITH NEWLY DIAGNOSED MASH OR SUSPECTED MASH WITH HIGH FIB-4 SCORE IN U.S. ADULTS
Mar 18, 2026, 21:38 PM -
HEALTHCARE BURDEN IN PATIENTS WITH HIDRADENITIS SUPPURATIVA: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
BUILDING RESILIENCY IN LIFE SCIENCES RESEARCH ORGANIZATIONS
Mar 18, 2026, 21:38 PM -
THE ECONOMIC IMPACT OF PERIOPERATIVE IMMUNE CHECKPOINT INHIBITORS IN RESECTABLE GASTRIC AND GASTROESOPHAGEAL JUNCTION CANCERS IN A CANADIAN SETTING
Mar 18, 2026, 21:38 PM -
RECEIPT OF SARS-COV2 MRNA VACCINE PRIOR TO IMMUNE CHECKPOINT INHIBITOR THERAPY ASSOCIATED WITH SIGNIFICANTLY IMPROVED OVERALL SURVIVAL ACROSS MULTIPLE METASTATIC CANCERS: RESULTS FROM A REAL-WORLD EVIDENCE STUDY
Mar 18, 2026, 21:38 PM -
FORECASTING CLINICAL OUTCOMES FROM LIMITED REAL-WORLD DATA: A COMPARATIVE SIMULATION STUDY
Mar 18, 2026, 21:38 PM -
A SYSTEMATIC REVIEW OF ONCOLYTIC VIRUSES AND GENE THERAPIES FOR RETINOBLASTOMA IN CHILDREN
Mar 18, 2026, 21:38 PM -
CLINICAL BENEFITS OF NIRMATRELVIR/RITONAVIR TREATMENT FOR COVID-19: A GLOBAL ECONOMIC VALUE SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
PSYCHOLOGICAL AND COMPETITIVE DETERMINANTS OF LOW BACK PAIN KNOWLEDGE AMONG COMPETITIVE ROWERS
Mar 18, 2026, 21:38 PM -
CLINICAL OUTCOMES AND ECONOMIC BURDEN FOLLOWING TREATMENT FOR UNRESECTABLE OR METASTATIC ESOPHAGEAL CANCER
Mar 18, 2026, 21:38 PM -
TRENDS AND ANNUALIZED CHANGES IN HUMAN PAPILLOMAVIRUS (HPV) VACCINATION AMONG ADOLESCENTS IN THE UNITED STATES, 2013-2023
Mar 18, 2026, 21:38 PM -
EVALUATING THE PATIENT BURDEN ASSOCIATED WITH DELAYED REIMBURSEMENT: A CASE STUDY OF PEMBROLIZUMAB IN THE TREATMENT OF ENDOMETRIAL CANCER IN CANADA
Mar 18, 2026, 21:38 PM -
COMPARING TEST-RETEST RELIABILITY AND RESPONSIVENESS OF EQ-5D-5L WITH FOUR BOLT-ONS, PROMIS-29 AND SKINDEX-16 IN PSORIASIS AND ATOPIC DERMATITIS PATIENTS
Mar 18, 2026, 21:38 PM
